Low Testosterone and Adverse Outcomes
Although low testosterone is common among middle aged and older men, supplementing testosterone therapy is considered to carry risks such as heart attacks or strokes. Northwest Clinical Research Center is involved in assessing such risks with a testosterone gel among middle aged and older men.
Testosterone replacement therapies are known for helping with such factors as libido, mood regulation, maintenance of sexual characteristics and sperm development and are thus widely used by men with Low T. However, existing clinical trial data do not specifically assess risks associated with long-term use of testosterone replacement medications. Thus, further research on this important topic is needed.
About the Study Medication
The current study is further evaluating a testosterone replacement therapy that is approved by the U.S. Food and Drug Administration.
Specifically, this is a long-term study to evaluate if use of Androgel 1.62%® is associated with increased cardiovascular events over a period of five years.
- Candidates who are ages 45-80 with Testosterone levels < 300 ng/dL.
- Low testosterone levels and some cardiovascular risk factors (hypertension, coronary artery disease, current smoker, diabetes).
No Cost Study
There is no cost to participate in the study, and the study participant will receive the following:
- Medical evaluation.
- Investigational Medication.
- Study Related Medical Care.
- Compensation up to $1,000.
- Complimentary transportation or a travel stipend.